综合分析了运动对妇女绝经后骨质疏松症的影响。
This Paper reviewed the effect of exercise on osteoporosis in postmenopausal women.
骨质疏松症随年龄增长出现加速性骨质丧失且在绝经后妇女中特别常见，使其有骨折的风险(如髋骨、腕骨、椎骨)。
Osteoporosis is accelerated bone loss with age and is particularly common amongst postmenopausal women, putting them at risk for fractures (hip, wrist, vertebrae).
雷洛昔芬还被用于防治绝经后妇女骨质疏松症。
Raloxifene is also used in prevention and treatment of osteoporosis in postmenopausal women.
绝经后骨质疏松症是一种代谢性骨疾病，是绝经后妇女雌激素水平降低导致破骨细胞的骨吸收大于成骨细胞的骨形成作用。
Postmenopausal osteoporosis is a kind of metabolic osteopathy, whose cause is that bone absorption of osteoclast is more forceful than osteogenesis of osteoblast.
雷洛昔芬是用来预防和治疗绝经后妇女的骨质疏松症的。
Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
在绝经后并且患有骨质疏松症的妇女中，颈动脉或者股动脉粥样硬化与低骨量之间的关系。骨保护素有作用吗。
The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role?
结论：应用阿仑磷酸钠治疗绝经后妇女骨质疏松症较他莫昔芬更为合理、经济。
Conclusion: Alendronate is more reasonable and economical than raloxifene in treating postmenopausal osteoporosis.
目的：评价运动疗法治疗绝经后妇女骨质疏松症的疗效。
OBJECTIVE: To evaluate the efficacy of exercise in postmenopausal women with osteoporosis.
绝经后骨质疏松症是一个重要的公共健康问题，有关运动疗法与绝经后妇女骨骼的研究越来越多。
Postmenopausal osteoporosis is a major public health concern. Many studies have been done involving exercise therapy and effect on BMD of postmenopausal women.
绝经后骨质疏松症是一个重要的公共健康问题，有关运动疗法与绝经后妇女骨骼的研究越来越多。
Postmenopausal osteoporosis is a major public health concern. Many studies have been done involving exercise therapy and effect on BMD of postmenopausal women.
应用推荐